 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 05/20/2022 |
$7.28 |
$7.28 |
$6.58 |
$6.81 |
640.40K | | 05/23/2022 |
$6.97 |
$6.97 |
$6.40 |
$6.47 |
690.80K | | 05/24/2022 |
$6.42 |
$6.53 |
$5.75 |
$5.93 |
800.30K | | 05/25/2022 |
$5.88 |
$5.88 |
$5.46 |
$5.48 |
675.50K | | 05/26/2022 |
$5.53 |
$5.65 |
$5.33 |
$5.43 |
820.00K |
|
|
| Aerie Pharmaceuticals is a pharmaceutical company focused on the discovery, development and commercialization of ophthalmic therapies for the treatment of patients with eye diseases and conditions including open-angle glaucoma, dry eye, and diabetic macular edema. Rhopressa® is a once-daily eye drop designed to reduce elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. Rocklatan® is a once-daily fixed-dose combination of Rhopressa® and latanoprost, a prescribed drug for the treatment of patients with open-angle glaucoma or ocular hypertension. Co. is developing AR-15512, an ophthalmic solution for the treatment of patients with dry eye disease. | |
|
Aerie Pharmaceuticals (AERI) has the following price history information. Looking back at AERI historical stock prices for the last five trading days, on May 20, 2022, AERI opened at $7.28, traded as high as $7.28 and as low as $6.58, and closed at $6.81. Trading volume was a total of 640.40K shares. On May 23, 2022, AERI opened at $6.97, traded as high as $6.97 and as low as $6.40, and closed at $6.47. Trading volume was a total of 690.80K shares. On May 24, 2022, AERI opened at $6.42, traded as high as $6.53 and as low as $5.75, and closed at $5.93. Trading volume was a total of 800.30K shares. On May 25, 2022, AERI opened at $5.88, traded as high as $5.88 and as low as $5.46, and closed at $5.48. Trading volume was a total of 675.50K shares. On May 26, 2022, AERI opened at $5.53, traded as high as $5.65 and as low as $5.33, and closed at $5.43. Trading volume was a total of 820.00K shares.
AERI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Aerie Pharmaceuticals shares, starting with a $10,000 purchase of AERI, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
10/28/2013 |
|
| End date: |
05/26/2022 |
|
| Start price/share: |
$10.55 |
|
| End price/share: |
$5.43 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-48.53% |
|
| Average Annual Total Return: |
-7.45% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,146.15 |
|
| Years: |
8.58 |
|
|
|
| Date |
Close |
| 05/20/2022 | $6.81 | | 05/23/2022 | $6.47 | | 05/24/2022 | $5.93 | | 05/25/2022 | $5.48 | | 05/26/2022 | $5.43 |
|
|
Free AERI Email Alerts:
